In the quick-shifting state of manufacturing, supply chain, and logistics, uncertainty still looms over the future, yet adaptation and resiliency have also created pockets of radical innovation. These innovations—combined with hard work and tenacity—have produced exciting new opportunities for the global industry as we begin to emerge from the COVID-19 pandemic.
Experts agree that the pandemic will influence the future of manufacturing beyond the immediate, quick-fire changes in the last year and a half. Businesses must build greater transparency, agility, resilience, responsibility, and responsiveness into their operations. Because the manufacturing sector is rebounding so quickly, the time to make substantial changes is running short.
These days you need a unified and connected view of your customer to execute that seamless experience through whatever touchpoint. Retailers and suppliers must be able to tease out trends for fulfillment strategies with the technology to make it happen.
The medical and biotech industry accounted for 15% of our total production. Three months later, it was 40%. The transition was far from perfect, but standardization made it possible to move from making parts for Tesla to manufacturing and producing ventilators and biotech.
During the early stages of the crisis, Generix executives decided to invest in our North American Product Development teams to leverage the economic slowdown and improve our product offerings. We had to double our team (from 75 to 150 employees) over nine months.
When companies understand security and privacy risks down to the level of each individual component, they can either mitigate them in some way or design around them and monitor the processes.